HomeEntertainmentReplimune reaches agreement with FDA on melanoma drug resubmission Replimune reaches agreement with FDA on melanoma drug resubmission May 29, 2026byadmin Replimune reaches agreement with FDA on melanoma drug resubmission Source link
Nuvectis Pharma stock tumbles 25% on discounted offering Nuvectis Pharma stock tumbles 25% on discounted offering Source link
Tonix CEO Seth Lederman buys $58,949 in company stock Tonix CEO Seth Lederman buys $58,949 in company stock Source link
Cathie Wood’s ARK buys Alphabet stock, sells AMD Cathie Wood’s ARK buys Alphabet stock, sells AMD Source link
